Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.


Woyach J. A., Qiu L., Grosicki S., Wrobel T., Capra M., Czyz J., ...Daha Fazla

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025 (SCI-Expanded, Scopus) identifier